Similar articles

• Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis.

  Raker VK, Ook KY, Haub J, Lorenz N, Schmidt T, Stegemann A, Böhm M, Schuppan D, Steinbrink K. Raker VK, et al. Exp Dermatol. 2016 Nov;25(11):887-894. doi: 10.1111/exd.13124. Exp Dermatol. 2016. PMID: 27307019
• Mouse model of experimental dermal fibrosis: the bleomycin-induced dermal fibrosis.

  Avouac J. Avouac J. Methods Mol Biol. 2014;1142:91-8. doi: 10.1007/978-1-4939-0404-4_11. Methods Mol Biol. 2014. PMID: 24706279
• The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis.

  Yoshizaki A, Yanaba K, Ogawa A, Iwata Y, Ogawa F, Takenaka M, Shimizu K, Asano Y, Kadono T, Sato S. Yoshizaki A, et al. Arthritis Rheum. 2011 Oct;63(10):3086-97. doi: 10.1002/art.30470. Arthritis Rheum. 2011. PMID: 21618208
• Skin fibrosis: Models and mechanisms.

  Do NN, Eming SA. Do NN, et al. Curr Res Transl Med. 2016 Oct-Dec;64(4):185-193. doi: 10.1016/j.retram.2016.06.003. Epub 2016 Nov 3. Curr Res Transl Med. 2016. PMID: 27939457 Review.
• Sphingolipids in pulmonary fibrosis.

  Huang LS, Natarajan V. Huang LS, et al. Adv Biol Regul. 2015 Jan;57:55-63. doi: 10.1016/j.jbior.2014.09.008. Epub 2014 Oct 13. Adv Biol Regul. 2015. PMID: 25446881 Free PMC article. Review.